211 related articles for article (PubMed ID: 7963444)
1. Pros and cons of BCG vaccination in countries with low incidence of tuberculosis.
Tala EO; Tala-Heikkilä MM
Infect Control Hosp Epidemiol; 1994 Jul; 15(7):497-9. PubMed ID: 7963444
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities.
Faust L; Schreiber Y; Bocking N
BMC Public Health; 2019 Nov; 19(1):1504. PubMed ID: 31711446
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
[TBL] [Abstract][Full Text] [Related]
4. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
[TBL] [Abstract][Full Text] [Related]
5. The BCG vaccine: information and recommendations for use in Australia.
National Tuberculosis Advisory Committee
Commun Dis Intell Q Rep; 2006; 30(1):109-15. PubMed ID: 16637239
[TBL] [Abstract][Full Text] [Related]
6. Economic Evaluation of Selective Neonatal Bacillus Calmette-Guérin Vaccination of High-risk Infants in Ireland.
Teljeur C; Moran PS; Harrington P; Butler K; Corcoran B; O'Donnell J; Usher C; O'Flanagan D; Connolly K; Ryan M
Pediatr Infect Dis J; 2018 Aug; 37(8):759-767. PubMed ID: 29432385
[TBL] [Abstract][Full Text] [Related]
7. [Amendment of tuberculosis prevention law and prospect of tuberculosis control program].
Ushio M
Kekkaku; 2005 Jul; 80(7):541-6. PubMed ID: 16167781
[TBL] [Abstract][Full Text] [Related]
8. Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland.
Sweeney E; Dahly D; Seddiq N; Corcoran G; Horgan M; Sadlier C
BMC Infect Dis; 2019 May; 19(1):397. PubMed ID: 31072396
[TBL] [Abstract][Full Text] [Related]
9. [BCG vaccines for the prevention of tuberculosis in the world].
Hashimoto T
Kekkaku; 1997 Nov; 72(11):629-37. PubMed ID: 9423301
[TBL] [Abstract][Full Text] [Related]
10. Health economic evaluation of current vaccination strategies and new vaccines against tuberculosis: a systematic review.
Machlaurin A; Pol SV; Setiawan D; van der Werf TS; Postma MJ
Expert Rev Vaccines; 2019 Sep; 18(9):897-911. PubMed ID: 31369299
[No Abstract] [Full Text] [Related]
11. A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland.
Hersh AL; Tala-Heikkilä M; Tala E; Tosteson AN; Fordham von Reyn C
Int J Tuberc Lung Dis; 2003 Jan; 7(1):22-9. PubMed ID: 12701831
[TBL] [Abstract][Full Text] [Related]
12. [Tuberculosis control strategy in the 21st century in Japan--for elimination of tuberculosis in Japan].
Aoki M
Kekkaku; 2001 Jul; 76(7):549-57. PubMed ID: 11517563
[TBL] [Abstract][Full Text] [Related]
13. The benefits and risks of bacille Calmette-Guérin vaccination among infants at high risk for both tuberculosis and severe combined immunodeficiency: assessment by Markov model.
Clark M; Cameron DW
BMC Pediatr; 2006 Mar; 6():5. PubMed ID: 16515694
[TBL] [Abstract][Full Text] [Related]
14. Neonatal BCG vaccination in Ireland: evidence of its efficacy in the prevention of childhood tuberculosis.
Kelly P; McKeown D; Clancy L
Eur Respir J; 1997 Mar; 10(3):619-23. PubMed ID: 9072995
[TBL] [Abstract][Full Text] [Related]
15. [Tuberculosis prevalence survey in Japan].
Shimao T
Kekkaku; 2009 Nov; 84(11):713-20. PubMed ID: 19999593
[TBL] [Abstract][Full Text] [Related]
16. Use of the bacille Calmette-Guérin vaccination for the prevention of tuberculosis: renewed interest in an old vaccine.
Cohn DL
Am J Med Sci; 1997 Jun; 313(6):372-6. PubMed ID: 9186153
[TBL] [Abstract][Full Text] [Related]
17. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
Moliva JI; Turner J; Torrelles JB
Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
[TBL] [Abstract][Full Text] [Related]
18. Beyond BCG: the potential for a more effective TB vaccine.
Orme IM
Mol Med Today; 1999 Nov; 5(11):487-92. PubMed ID: 10529790
[TBL] [Abstract][Full Text] [Related]
19. [Reform of Japan's NTP and its technical perspectives].
Mori T
Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
[TBL] [Abstract][Full Text] [Related]
20. Evidence of protective effect of BCG vaccination in persons at low risk of tuberculosis in Nordic countries.
Brantsaeter AB; Romanus V; Andersen PH; Heldal E
Int J Tuberc Lung Dis; 2009 Apr; 13(4):440-5. PubMed ID: 19335948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
